You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 25, 2025

Details for Patent: 11,253,492


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,253,492
Title:Bupropion as a modulator of drug activity
Abstract: Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
Inventor(s): Tabuteau; Herriot (New York, NY)
Assignee: ANTECIP BIOVENTURES II LLC (New York, NY)
Application Number:17/196,338
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using USPTO Resources

Introduction

When analyzing the scope and claims of a U.S. patent, such as United States Patent 11,253,492, it is crucial to utilize the various resources and tools provided by the United States Patent and Trademark Office (USPTO). This article will guide you through the process, highlighting key resources, methodologies, and insights that can help you understand the patent landscape.

Understanding the Patent Document

To begin, you need to obtain and review the patent document itself. The USPTO provides several ways to access patent documents:

Patent Public Search

The Patent Public Search tool is a modern web-based application that replaces legacy search tools. It offers enhanced access to prior art and allows users to search for patents using various criteria such as patent numbers, keywords, and classification codes[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs can also provide access to patent documents and offer training in patent search techniques. These centers are invaluable for those needing hands-on assistance[1].

Analyzing Patent Claims

Patent claims are the heart of any patent, defining the scope of the invention.

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset can help in understanding claim structures, dependencies, and statistical analyses related to patent scope[3].

Claim-Level Statistics

The dataset includes claim-level statistics and document-level statistics, such as newly-developed measures of patent scope. These statistics can be used to compare the claims of the patent in question with broader trends in patenting within the same technology field[3].

Examining the Patent Scope

Understanding the scope of a patent involves analyzing its claims in the context of prior art and the broader patent landscape.

Common Citation Document (CCD)

The CCD application consolidates prior art citations from the IP5 Offices, allowing users to visualize the search results for the same invention produced by several offices on a single page. This tool is essential for identifying relevant prior art and understanding how different patent offices have treated similar inventions[1].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices. This includes classification, citation data, and office actions, which can help in assessing the patent's scope and its position within the global patent family[1].

Assessing Patent Allowance Rates

Understanding the probability of a patent being allowed can provide context on the patent's validity and the rigor of the examination process.

Patent Allowance Rates

Studies on patent allowance rates, such as those conducted by the USPTO, provide insights into the likelihood of a patent being granted. These studies differentiate between first-action allowance rates, progenitor allowance rates, and family allowance rates, offering a comprehensive view of the patent's journey through the examination process[4].

Continuation Procedures

Continuation procedures can significantly impact the scope and claims of a patent.

Non-Serialized and Serialized Continuations

Continuation procedures, such as Requests for Continued Examination (RCEs) and continuation-in-part (CIP) applications, can introduce new subject matter or separate distinct inventions. Understanding these procedures is crucial for tracing the evolution of the patent and its claims[4].

Legal and Policy Considerations

The legal and policy framework surrounding patents is constantly evolving.

Small Claims Patent Court

Recent studies by the Administrative Conference of the United States (ACUS) on the feasibility of a small claims patent court highlight ongoing efforts to streamline patent litigation and make the patent system more accessible to smaller entities[5].

Practical Steps for Analysis

Step 1: Retrieve the Patent Document

Use the Patent Public Search tool or visit a PTRC to obtain the full text of the patent.

Step 2: Analyze Claims

Review the claims section of the patent and compare them with the Patent Claims Research Dataset to understand the claim structure and dependencies.

Step 3: Examine Prior Art

Utilize the CCD application to consolidate prior art citations and assess how different patent offices have treated similar inventions.

Step 4: Assess Global Context

Use the Global Dossier service to view the file histories of related applications and understand the patent's position within the global patent family.

Step 5: Evaluate Allowance Rates

Refer to studies on patent allowance rates to understand the probability of the patent being granted and the rigor of the examination process.

Step 6: Consider Continuation Procedures

Identify any continuation procedures used in the patent's history to understand how the claims and scope may have evolved.

Example: Analyzing United States Patent 11,253,492

To illustrate this process, let's consider a hypothetical analysis of United States Patent 11,253,492:

  • Retrieve the Patent Document: Use the Patent Public Search tool to retrieve the full text of the patent.
  • Analyze Claims: Review the claims section and compare it with the Patent Claims Research Dataset to understand the claim structure.
  • Examine Prior Art: Use the CCD application to consolidate prior art citations.
  • Assess Global Context: Use the Global Dossier service to view related applications.
  • Evaluate Allowance Rates: Refer to studies on patent allowance rates to understand the patent's journey through the examination process.
  • Consider Continuation Procedures: Identify any continuation procedures used.

Key Takeaways

  • Utilize USPTO Resources: Leverage tools like Patent Public Search, Global Dossier, and the Patent Claims Research Dataset to analyze patents comprehensively.
  • Understand Claims: Analyze the claim structure and dependencies to define the scope of the invention.
  • Assess Prior Art: Consolidate prior art citations to understand how different patent offices have treated similar inventions.
  • Evaluate Global Context: View the file histories of related applications to understand the patent's position within the global patent family.
  • Consider Legal and Policy Frameworks: Stay updated on legal and policy changes, such as the potential for a small claims patent court.

FAQs

Q: How can I access the full text of a U.S. patent?

You can access the full text of a U.S. patent using the Patent Public Search tool on the USPTO website or by visiting a Patent and Trademark Resource Center (PTRC)[1].

Q: What is the Common Citation Document (CCD) application?

The CCD application consolidates prior art citations from the IP5 Offices, allowing users to visualize the search results for the same invention produced by several offices on a single page[1].

Q: How do continuation procedures affect patent claims?

Continuation procedures, such as RCEs and CIP applications, can introduce new subject matter or separate distinct inventions, potentially altering the scope and claims of the patent[4].

Q: What is the Global Dossier service?

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, including classification, citation data, and office actions[1].

Q: Why is understanding patent allowance rates important?

Understanding patent allowance rates provides insights into the likelihood of a patent being granted and the rigor of the examination process, which can be crucial for assessing the patent's validity and scope[4].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. YJOLT - What Is the Probability of Receiving a US Patent?: https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,253,492

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Axsome AUVELITY bupropion hydrochloride; dextromethorphan hydrobromide TABLET, EXTENDED RELEASE;ORAL 215430-001 Aug 18, 2022 RX Yes Yes 11,253,492 ⤷  Try for Free DEXTROMETHORPHAN AND BUPROPION IN COMBINATION TO TREAT MAJOR DEPRESSIVE DISORDER ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.